Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there a solution for recurrent endometriosis?

J L Evers1, G A Dunselman, J A Land

  • 1Department of Obstetrics and Gynecology, Academisch Ziekenhuis Maastricht, The Netherlands.

British Journal of Clinical Practice. Supplement
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the Mikrogen multi-target ELISA with the Mikrogen recomLine immunoblot for the detection of Chlamydia trachomatis IgG antibodies in serum in infertile women.

Journal of microbiological methods·2018
Same author

Chromosomal abnormalities in 1663 infertile men with azoospermia: the clinical consequences.

Human reproduction (Oxford, England)·2017
Same author

Cost-effectiveness analysis of lifestyle intervention in obese infertile women.

Human reproduction (Oxford, England)·2017
Same author

The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women.

BMC infectious diseases·2017
Same author

Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.

Human reproduction (Oxford, England)·2016
Same author

Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.

Human reproduction (Oxford, England)·2016

Endometriosis recurrence rates can reach 45% within five years, often based on symptomatic patients. The exact cause of recurring symptoms requires further investigation for effective endometriosis treatment.

Area of Science:

  • Gynecology
  • Reproductive Medicine
  • Surgical Innovation

Background:

  • Endometriosis presents as symptomatic or asymptomatic disease.
  • Recurrence rates are primarily derived from symptomatic patients seeking medical attention.
  • Established recurrence rates indicate up to 45% of patients may experience symptom recurrence within five years post-treatment.

Purpose of the Study:

  • To analyze the reported recurrence rates of endometriosis.
  • To investigate the underlying causes of recurrent endometriosis symptoms.
  • To inform tailored therapeutic strategies for endometriosis management.

Main Methods:

  • Review of clinical data focusing on symptomatic endometriosis patients.
  • Analysis of recurrence rates following medical and surgical interventions.

Related Experiment Videos

  • Evaluation of the distinction between true disease recurrence and the expansion of microscopic implants.

    • Main Results:

    • Recurrence rates up to 45% observed in symptomatic patients within five years.
    • Uncertainty remains regarding whether symptoms stem from true recurrence or expanding microscopic implants.
    • Current data does not definitively differentiate between recurrent disease and progression of existing microscopic lesions.

    Conclusions:

    • Endometriosis recurrence rates are significant, particularly in symptomatic individuals.
    • Further research is needed to clarify the pathophysiology of symptom recurrence.
    • Therapeutic approaches for recurrent endometriosis should be individualized based on patient symptoms, potentially mirroring primary disease treatment.